ITV agrees to airtime for equity deal with Flarin

By

1 minute

ITV’s airtime for equity fund, ITV AdVentures Invest, has agreed to provide up to £5m in ad inventory across ITV’s channels in return for a minority equity stake in the pain relief brand.

Ella Sagar Avatar

Ella Sagar Ella Sagar is a reporter for The Media Leader and leads our audio and out-of-home coverage. She joined in September 2021 and has a gold standard NCTJ. She previously wrote for the South West Londoner, Ealing Times, and The Hillingdon Times. At the University of Leeds, she received a First Class Honours Degree in French and Spanish with distinction in speaking and during her time there regularly presented radio shows on Leeds Student Radio, wrote for the student paper The Gryphon and was editor of Her Campus Leeds.


ITV’s airtime for equity fund, ITV AdVentures Invest, has agreed to provide up to £5m in ad inventory across ITV’s channels in return for a minority equity stake in pain relief brand Flarin.

This follows similar investments in architectural design company Resi and pet health and wellness brand PitPat agreed earlier this year.

Sheena Amin, director of ITV AdVentures since September 2022, said of the deal: “Flarin is already one of the fastest growing analgesics in the market and I am confident that we will see the company grow to new heights following a brand building campaign across ITV.”


Explore more topics


Want to get involved in the discussion?